286 related articles for article (PubMed ID: 31423502)
21. A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care.
Yi S; Yang F; Jie C; Zhang G
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3438-3447. PubMed ID: 31411066
[TBL] [Abstract][Full Text] [Related]
22. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
[TBL] [Abstract][Full Text] [Related]
23. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies.
Taghizadehghalehjoughi A; Hacimuftuoglu A; Cetin M; Ugur AB; Galateanu B; Mezhuev Y; Okkay U; Taspinar N; Taspinar M; Uyanik A; Gundogdu B; Mohammadzadeh M; Nalci KA; Stivaktakis P; Tsatsakis A; Jung TW; Jeong JH; Abd El-Aty AM
Nanomedicine (Lond); 2018 Jul; 13(13):1595-1606. PubMed ID: 30028222
[TBL] [Abstract][Full Text] [Related]
24. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting.
Chu L; Wang A; Ni L; Yan X; Song Y; Zhao M; Sun K; Mu H; Liu S; Wu Z; Zhang C
Drug Deliv; 2018 Nov; 25(1):1634-1641. PubMed ID: 30176744
[TBL] [Abstract][Full Text] [Related]
25. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
26. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract][Full Text] [Related]
27. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma.
Wang K; Kievit FM; Jeon M; Silber JR; Ellenbogen RG; Zhang M
Adv Healthc Mater; 2015 Dec; 4(17):2719-26. PubMed ID: 26498165
[TBL] [Abstract][Full Text] [Related]
29. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development.
Maksimenko O; Malinovskaya J; Shipulo E; Osipova N; Razzhivina V; Arantseva D; Yarovaya O; Mostovaya U; Khalansky A; Fedoseeva V; Alekseeva A; Vanchugova L; Gorshkova M; Kovalenko E; Balabanyan V; Melnikov P; Baklaushev V; Chekhonin V; Kreuter J; Gelperina S
Int J Pharm; 2019 Dec; 572():118733. PubMed ID: 31689481
[TBL] [Abstract][Full Text] [Related]
31. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.
Ferreira NN; Granja S; Boni FI; Prezotti FG; Ferreira LMB; Cury BSF; Reis RM; Baltazar F; Gremião MPD
Drug Deliv Transl Res; 2020 Dec; 10(6):1729-1747. PubMed ID: 32683647
[TBL] [Abstract][Full Text] [Related]
32. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
33. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
34. Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment.
Ye Z; Gao L; Cai J; Wang Y; Li Y; Tong S; Yan T; Sun Q; Qi Y; Xu Y; Jiang H; Zhang S; Zhao L; Zhang S; Chen Q
Nanomedicine; 2022 Aug; 44():102581. PubMed ID: 35811067
[TBL] [Abstract][Full Text] [Related]
35. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice.
Qin H; Jiang Y; Zhang J; Deng C; Zhong Z
Mol Pharm; 2019 Aug; 16(8):3711-3719. PubMed ID: 31299161
[TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma.
Locatelli E; Naddaka M; Uboldi C; Loudos G; Fragogeorgi E; Molinari V; Pucci A; Tsotakos T; Psimadas D; Ponti J; Franchini MC
Nanomedicine (Lond); 2014 May; 9(6):839-49. PubMed ID: 24433240
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma.
Ganipineni LP; Ucakar B; Joudiou N; Riva R; Jérôme C; Gallez B; Danhier F; Préat V
J Drug Target; 2019; 27(5-6):614-623. PubMed ID: 30633585
[TBL] [Abstract][Full Text] [Related]
38. Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein.
Mahmud H; Kasai T; Khayrani AC; Asakura M; Oo AKK; Du J; Vaidyanath A; El-Ghlban S; Mizutani A; Seno A; Murakami H; Masuda J; Seno M
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495404
[TBL] [Abstract][Full Text] [Related]
39. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
[TBL] [Abstract][Full Text] [Related]
40. Chlorotoxin-A Multimodal Imaging Platform for Targeting Glioma Tumors.
Cohen G; Burks SR; Frank JA
Toxins (Basel); 2018 Nov; 10(12):. PubMed ID: 30486274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
